Pelthos Therapeutics Inc.
PTHS
$25.38
$0.240.96%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -857.97% | -94.68% | 23.21% | 52.30% | -19.23% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -99.04% | -- | -84.45% | 194.77% | -95.26% |
| Total Other Non-Cash Items | 3,052.56% | -9.91% | 66.03% | -83.52% | -28.60% |
| Change in Net Operating Assets | -472.13% | 247.80% | 330.52% | 19.49% | 85.58% |
| Cash from Operations | -8,486.78% | 84.86% | 68.27% | -87.86% | 30.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 107.58% | -76.37% | -- | -187.89% | -552.95% |
| Total Debt Repaid | -422,400.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -67.66% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,846.09% | -76.37% | -95.59% | -116.54% | -590.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,334.61% | 94.72% | -110.40% | -1,107.47% | -1,845.35% |